Prevention of diabetic complications by activation of Nrf2: diabetic cardiomyopathy and nephropathy.
about
Interplay of oxidative, nitrosative/nitrative stress, inflammation, cell death and autophagy in diabetic cardiomyopathySpotlights on immunological effects of reactive nitrogen species: When inflammation says nitric oxideDiabetic Microvascular Disease and Pulmonary Fibrosis: The Contribution of Platelets and Systemic InflammationNrf2 modulates contractile and metabolic properties of skeletal muscle in streptozotocin-induced diabetic atrophySulforaphane Protects against Cardiovascular Disease via Nrf2 ActivationGinkgolide B reduces LOX-1 expression by inhibiting Akt phosphorylation and increasing Sirt1 expression in oxidized LDL-stimulated human umbilical vein endothelial cellsCalcium sensing receptor protects high glucose-induced energy metabolism disorder via blocking gp78-ubiquitin proteasome pathwayTranscriptome-based analysis of kidney gene expression changes associated with diabetes in OVE26 mice, in the presence and absence of losartan treatmentAntioxidant Treatment Induces Hyperactivation of the HPA Axis by Upregulating ACTH Receptor in the Adrenal and Downregulating Glucocorticoid Receptors in the Pituitary.Nrf2 upregulates ATP binding cassette transporter expression and activity at the blood-brain and blood-spinal cord barriersThe role of Nrf2-mediated pathway in cardiac remodeling and heart failure.Multiple low-dose radiation prevents type 2 diabetes-induced renal damage through attenuation of dyslipidemia and insulin resistance and subsequent renal inflammation and oxidative stress.Inhibition of JNK by compound C66 prevents pathological changes of the aorta in STZ-induced diabetesAnti-inflammatory activity of Barleria lupulina: Identification of active compounds that activate the Nrf2 cell defense pathway, organize cortical actin, reduce stress fibers, and improve cell junctions in microvascular endothelial cells.Prevention of diabetic nephropathy by sulforaphane: possible role of Nrf2 upregulation and activation.Sulforaphane prevention of diabetes-induced aortic damage was associated with the up-regulation of Nrf2 and its down-stream antioxidants.Plasma plasminogen activator inhibitor-1 is associated with end-stage proliferative diabetic retinopathy in the Northern Chinese Han population.Diabetic nephropathy: the role of inflammation in fibroblast activation and kidney fibrosis.Diabetes causes bone marrow endothelial barrier dysfunction by activation of the RhoA-Rho-associated kinase signaling pathway.Zinc protects against diabetes-induced pathogenic changes in the aorta: roles of metallothionein and nuclear factor (erythroid-derived 2)-like 2.Therapeutic effect of MG132 on the aortic oxidative damage and inflammatory response in OVE26 type 1 diabetic mice.Broccoli sprout extract prevents diabetic cardiomyopathy via Nrf2 activation in db/db T2DM miceOverexpression of DJ-1 reduces oxidative stress and attenuates hypoxia/reoxygenation injury in NRK-52E cells exposed to high glucose.Analysis of serum and urinal copper and zinc in Chinese northeast population with the prediabetes or diabetes with and without complications.Genetic variants of nuclear factor erythroid-derived 2-like 2 associated with the complications in Han descents with type 2 diabetes mellitus of Northeast ChinaDiabetic cardiomyopathy and its prevention by nrf2: current status.Diabetic cardiomyopathy and its mechanisms: Role of oxidative stress and damage.Caffeoylserotonin protects human keratinocyte HaCaT cells against H2 O2 -induced oxidative stress and apoptosis through upregulation of HO-1 expression via activation of the PI3K/Akt/Nrf2 pathway.Aldose Reductase Inhibitor Protects against Hyperglycemic Stress by Activating Nrf2-Dependent Antioxidant ProteinsRole of Nrf2 Signaling in the Regulation of Vascular BK Channel β1 Subunit Expression and BK Channel Function in High-Fat Diet-Induced Diabetic Mice.The Role of Nrf2 in Cardiovascular Function and Disease.Therapeutic effect of MG-132 on diabetic cardiomyopathy is associated with its suppression of proteasomal activities: roles of Nrf2 and NF-κB.Potential role for Nrf2 activation in the therapeutic effect of MG132 on diabetic nephropathy in OVE26 diabetic mice.Regulation of vascular large-conductance calcium-activated potassium channels by Nrf2 signalling.Diphlorethohydroxycarmalol Attenuates Methylglyoxal-Induced Oxidative Stress and Advanced Glycation End Product Formation in Human Kidney Cells.Recent novel approaches to limit oxidative stress and inflammation in diabetic complications.Astaxanthin Promotes Nrf2/ARE Signaling to Alleviate Renal Fibronectin and Collagen IV Accumulation in Diabetic Rats.Paeonol Ameliorates Diabetic Renal Fibrosis Through Promoting the Activation of the Nrf2/ARE Pathway via Up-Regulating Sirt1.
P2860
Q27001165-ADE3517D-F0D3-4007-B229-3DD058E53873Q27694770-F9861F08-FCD1-47B6-AFE1-A099A4038DCBQ28073977-982EDA85-1EB9-4526-A988-B1995E104637Q28390266-E0A850BA-953A-4DE4-8F82-D1950BD21BD5Q28393421-5721BDDF-41F5-4A1C-BD1D-B849AD240472Q28533547-E6460FE0-5C2B-4CCA-839A-CC2E59D3E1E5Q32872021-6A1368A7-1271-47A5-B864-5BFD64706A92Q33610151-A4738AD0-7548-4B6D-A02E-B2F46C7CDBE3Q33760186-337D9CBA-1AB7-478A-B9E2-E22DD46688D6Q33770428-C71A3EF6-9B28-44A9-BECE-E30504A6714CQ33914944-B23F6E3E-48E5-46AA-A52A-7F074C200C6DQ35126070-43D52495-AE8B-49B3-9AEE-8F2D8EB23C6BQ35867965-6D31B4B2-34E9-4A05-888E-CF350D1389E3Q36142104-C18CA8B2-F9B8-4F4E-989A-2CF377F9DAE6Q36289400-1571D8E7-3AAD-45F7-8DC9-0F791ADBD93AQ36392375-318427D4-85D8-4912-8743-8C12A5A818FBQ36457938-AB18C6A4-DBBE-4F12-A47F-917187FDA5BFQ36589609-8AEDC21A-53C2-4C1C-A127-4999B4972952Q36739754-3F81449E-9BA7-42E9-87F9-5BD3C2E4864FQ36753482-C265F259-4B61-4EE7-8099-87AD4E568851Q36754958-E8F3F8A3-2E72-4C55-8B36-589297CA2A76Q37125260-F9A88437-D0D2-4A6A-B58C-ACE4A7BCDB18Q37187517-3E87BEE8-9334-45D9-B7C2-6D142230A42CQ37224803-DAF5EE35-9694-4671-9ECD-B223DFC6EA8BQ37370799-5D88D1D9-B3F5-4D86-B58B-93A2B9AC2B76Q38263221-C0C63822-AD45-4484-8DAC-778B946376C8Q38271210-03198702-414B-4BC9-800E-7941FD5F5C3BQ39192806-DD38D155-0A72-46D9-8229-B031D3F51802Q40979631-8A0701CF-E4E0-4DE7-8F71-2AC53DDDC557Q41972825-505A8067-E26F-4609-9D3E-8C966BE24181Q43372995-F83B86E8-9FC7-4EB5-ABED-809CFF65072CQ44010395-EF654101-CDA2-4FE3-A1FA-10EB897ADB9DQ45775555-FF513F66-6BDD-4FC8-A1AA-104A3597662FQ51042757-6D3DA7FE-1D60-4E10-9179-9E560DBDA9EFQ54949436-9FB33283-1D34-4775-8FB6-DEEC48A83297Q54956778-BD6262C5-BB9D-4711-8845-3B9939BB25CCQ55128663-B91FD2E7-F557-47F6-A78A-CC6393031C0DQ55261493-BFB98E5B-5DB4-4A7F-B487-13608256BE0D
P2860
Prevention of diabetic complications by activation of Nrf2: diabetic cardiomyopathy and nephropathy.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Prevention of diabetic complic ...... ardiomyopathy and nephropathy.
@en
type
label
Prevention of diabetic complic ...... ardiomyopathy and nephropathy.
@en
prefLabel
Prevention of diabetic complic ...... ardiomyopathy and nephropathy.
@en
P2093
P2860
P921
P356
P1476
Prevention of diabetic complic ...... ardiomyopathy and nephropathy.
@en
P2093
P2860
P304
P356
10.1155/2012/216512
P5008
P577
2012-05-08T00:00:00Z